Edap Tms SA
EDAP1.270USD
-0.030-2.31%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
47.49MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Edap Tms SA Unternehmen
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Unternehmensinformationen
BörsenkürzelEDAP
Name des UnternehmensEdap Tms SA
IPO-datumAug 01, 1997
CEOJean-Francois Bachelard
Anzahl der mitarbeiter310
WertpapierartDepository Receipt
GeschäftsjahresendeAug 01
Addresse4, rue du Dauphine
StadtVAULX-EN-VELIN
BörseNASDAQ Global Market Consolidated
LandFrance
Postleitzahl69120
Telefon33472153150
Websitehttps://focalone.com/fr/accueil/
BörsenkürzelEDAP
IPO-datumAug 01, 1997
CEOJean-Francois Bachelard
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
--
--
Jean-Francois Bachelard
Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Jeon Jon-hyeon
Jeon Jon-hyeon
General Manager of EDAP TMS Korea
General Manager of EDAP TMS Korea
--
--
Alex Fromm
Alex Fromm
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
--
--
Frederic Pech
Frederic Pech
President of EDAP TMS France SAS
President of EDAP TMS France SAS
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
--
--
Jean-Francois Bachelard
Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Jeon Jon-hyeon
Jeon Jon-hyeon
General Manager of EDAP TMS Korea
General Manager of EDAP TMS Korea
--
--
Alex Fromm
Alex Fromm
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
--
--
Frederic Pech
Frederic Pech
President of EDAP TMS France SAS
President of EDAP TMS France SAS
--
--
Umsatzaufteilung
Währung: EURAktualisiert: Sun, Jul 6
Währung: EURAktualisiert: Sun, Jul 6
FY2024
Keine Daten
Nach RegionEUR
Name
Umsatz
Anteil
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Thu, Jul 24
Aktualisiert: Thu, Jul 24
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
9.00%
Rock Springs Capital Management LP
3.40%
Dubly Transatlantique Gestion
1.95%
Bruce & Company, Inc.
1.48%
Other
64.63%
Aktionäre
Aktionäre
Anteil
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
9.00%
Rock Springs Capital Management LP
3.40%
Dubly Transatlantique Gestion
1.95%
Bruce & Company, Inc.
1.48%
Other
64.63%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
27.23%
Research Firm
9.12%
Investment Advisor
4.88%
Investment Advisor/Hedge Fund
0.23%
Other
58.54%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
83
15.50M
41.46%
-2.31M
2025Q1
89
15.47M
41.38%
-2.38M
2024Q4
92
15.39M
41.47%
-2.59M
2024Q3
91
15.67M
42.24%
-3.03M
2024Q2
88
16.06M
43.28%
-2.91M
2024Q1
94
16.22M
43.72%
-3.26M
2023Q4
91
15.98M
43.08%
-4.16M
2023Q3
94
15.98M
43.28%
-3.85M
2023Q2
97
16.26M
44.04%
-2.56M
2023Q1
99
14.83M
40.17%
-3.58M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Soleus Capital Management, L.P.
7.31M
19.55%
--
--
Mar 31, 2025
Morgan Stanley & Co. International Plc
3.36M
9%
-3.01K
-0.09%
Mar 31, 2025
Rock Springs Capital Management LP
1.27M
3.4%
-321.80K
-20.22%
Mar 31, 2025
Dubly Transatlantique Gestion
730.70K
1.95%
+720.50K
+7063.72%
Mar 31, 2025
Bruce & Company, Inc.
553.65K
1.48%
--
--
Mar 31, 2025
Apis Capital Advisors LLC
524.00K
1.4%
+5.00K
+0.96%
Mar 31, 2025
Scoggin Management LP
350.00K
0.94%
+350.00K
--
Mar 31, 2025
Archon Capital Management LLC
273.61K
0.73%
-709.07K
-72.16%
Mar 31, 2025
Schonfeld Strategic Advisors LLC
166.43K
0.45%
+5.63K
+3.50%
Mar 31, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
